Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.075 | 0.7 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |